A world first, this standard certifies companies that promote health in
the workplace with a "seal of quality"
To access a multimedia version of this release, please visit:
KIRKLAND, QC, May 27 /CNW Telbec/ - Pfizer Canada Inc. recently obtained
the Healthy Enterprise - Elite certification from the Bureau de normalisation
du Québec (BNQ). The BNQ develops Quebec, Canadian and international standards
and is accredited by the Standards Council of Canada (SCC). The BNQ certifies
that the pro-health organizational practices implemented by the company comply
with this level of certification. Pfizer Canada is one of the first companies
to be certified under this standard. The certification applies to the entire
company and covers its personnel both at the Head Office in Quebec and
"We are very proud that we have obtained this certification, as it is a
true reflection of our corporate values and our philosophy that it takes more
than medication to be truly healthy," says Paul Lévesque, President of Pfizer
Canada Inc. "Through our health and wellness program, we do our utmost to
promote a healthy living and working environment. It is a major asset for
Pfizer and a program that is a natural fit for a company that devotes itself
to improving the health and quality of life of Canadians."
A world first
The BNQ created the Healthy Enterprise certification program in
collaboration with the Group for Prevention and Promotion Strategies (GP2S),
which initiated this project with support from the Fondation Lucie et André
Chagnon when it started up in 2005. The standard was officially launched in
February 2008, and the implementation of the certification program followed.
This occupational health standard is the first in the world of its kind, and
it is part of the Quebec government's Action Plan to Promote Healthy Life
Habits and Prevent Weight-Related Problems, 2006-2012.
The standard offers two levels of certification: Healthy Enterprise and
Healthy Enterprise - Elite. In addition to demonstrating their commitment in a
structured fashion and getting their managers involved in promoting workplace
wellness, Elite-level certified companies are required to take action in all
four areas of activity known to have a significant impact on employee health:
lifestyle habits, work-life balance, work environment and management
A well-structured program
It is thanks largely to its health and wellness program that Pfizer
Canada just obtained Healthy Enterprise - Elite certification. Pfizer Canada's
employee health and well-being program, VIVA, which was launched in May 2007,
is an integrated program centred on disease prevention, awareness of healthy
living and employee support. The program promotes healthy lifestyle habits in
various areas, such as nutrition, physical activity, work-life balance, and
stress management. The VIVA program is aimed at inspiring employees to look
after themselves and at helping them achieve their wellness objectives,
whatever they might be.
"This initiative is making a positive contribution to our employees' high
level of engagement, and the results are clear. More than three-quarters of
the employees surveyed in December 2008 said that the VIVA program adds value
to their jobs," says Luc St-Pierre, Pfizer Canada's Vice President of Human
Resources. "It's important to us that we provide all of our employees with a
stimulating, respectful and safe work environment that is supportive of
healthy lifestyle habits."
A productive social commitment
"I am very glad to see the interest of a large pharmaceutical company
like Pfizer in the Healthy Enterprise standard," emphasizes BNQ director
Jacques Girard, P.Eng. "Taking its employees' health into consideration using
this reference constitutes a gesture of social commitment. Not only is the
company investing in its employees' health, but one of the stated objectives
of this standard is that the good habits developed by employees be passed on
directly to their families and helps relieve the pressure on health services
in the medium and long term."
Quebec presently devotes 45% of its budget to health, an increase of 6%
since 2003. Mental health problems cost Canadian companies $33 billion in
direct and indirect costs. Recent studies identified by the Group for
Prevention and Promotion Strategies (GP2S) show that each dollar invested in
such programs yields between $1.50 and $3 in productivity gains within five
years of their implementation. Companies benefit from integrating healthy
values for people in their environment.
About Pfizer Canada
Pfizer Inc is the world's leading pharmaceutical company. Pfizer invests
more than $7 billion annually to discover and develop life-saving and
life-enhancing medications for humans and animals. The company's Canadian
operation, Pfizer Canada Inc., is one of the largest contributors to health
research in Canada.
Pfizer Canada and its cross-Canada team of 1,400 employees are working
together for a healthier world. Pfizer Canada's commitment to helping
Canadians live happier, healthier and longer lives extends well beyond the
brand-name medications that it offers. Its commitment is reflected in
everything it does, from its disease awareness initiatives to its community
partnerships. To learn more about Pfizer Canada's 'more than medication'
philosophy and program, visit www.morethanmedication.ca.
About the Bureau de normalisation du Québec
The Bureau de normalisation du Québec (BNQ) provides solutions to market
needs by developing balanced-committee consensus standards, implementing
certification programs and certifying systems. The BNQ's mission is to act as
a partner with the business, industrial, social and regulatory sectors in
order to help improve the quality of products, processes and services, and
their acceptance in all markets.
The Group for Prevention and Promotion Strategies (GP2S) is a group of
firms devoted to promoting occupational health and disease prevention. Funded
at its inception by the Fondation Lucie et André Chagnon, it is now supported
by 115 member companies and organizations, including its four governing
members: the Mouvement Desjardins, Alcoa Canada, Hydro-Québec and Pfizer
For further information:
For further information: Julie-Catherine Racine, Corporate
Communications, Pfizer Canada Inc., (514) 693-4602; Marie-Claude Drouin, MBA,
Business Development Advisor Bureau de normalisation du Québec, (418)
652-2211; Roch Landriault, NATIONAL Public Relations, (514) 843-2345